Evolution of the surgical treatment of lung cancer at a tertiary referral center in Brazil, 2011-2018

• Published in: Jornal brasileiro de pneumologia 2021-01, Vol.47 (1), p.e20190426-e20190426
• Main Authors: Soares, Mariana Schettini, Coltro, Laura Maria, Leite, Pedro Henrique Cunha, Costa, Priscila Berenice, Lauricella, Letícia Leone, Pêgo-Fernandes, Paulo Manuel, Terra, Ricardo Mingarini
• Format: Article
• Language: English
• Subjects: Brazil - epidemiology; Female; Humans; Lung Neoplasms - pathology; Lung Neoplasms - surgery; Lung neoplasms/epidemiology; Lung neoplasms/therapy; Neoplasm Staging; Original; RESPIRATORY SYSTEM; Retrospective Studies; Survival analysis; Survival Rate; Tertiary Care Centers; Thoracic surgery; Thoracic surgery, video-assisted
• ISSN: 1806-3756; 1806-3713; 1806-3756
• DOI: 10.36416/1806-3756/e20190426

To evaluate the evolution of clinical and epidemiological data, as well as data related to diagnosis, staging, treatment, and survival, among patients undergoing curative surgery for lung cancer at a tertiary referral center in the city of São Paulo, Brazil. This was a retrospective study of cases in the International Association for the Study of Lung Cancer database. We selected only cases of patients undergoing curative surgery between January of 2011 and April of 2018. We determined overall and disease-free survival at 36 months and compared the data between two periods (2011-2014 and 2015-2018). Comparing the two periods (N = 437 cases), we observed trends toward increases in the number of female patients, as well as in the proportions of former smokers (44.09% vs. 53.59%), of patients diagnosed with adenocarcinoma (52.21% vs. 59.72%), and of patients diagnosed at an earlier pathological stage, together with a decrease in 30-day mortality (4.05% vs. 2.39%). There were significant increases in the proportions of cases diagnosed at an earlier clinical stage (p = 0.002) or incidentally (p = 0.003). Although lobectomy was the main surgical technique employed, there was a proportional increase in segmentectomies (2.67% vs. 7.11%; p = 0.026). Overall and disease-free survival rates were 79.4% (95% CI: 74.0-83.9%) and 75.1% (95% CI: 69.1-80.1%), respectively. The difference in overall survival between the periods lost statistical significance when adjusted for pathological stage, the only factor that affected survival (log-rank: p = 0.038 to p = 0.079). The clinical and epidemiological evolution presented in this study corroborates global trends. The decrease in 30-day mortality was probably due to better patient selection and improved surgical techniques.